Issue 5, 2019

Optimizing the Cu-RDRP of N-(2-hydroxypropyl) methacrylamide toward biomedical applications

Abstract

Aqueous Cu-RDRP of N-(2-hydroxypropyl) methacrylamide, a monomer with important biomedical applications, was optimized with respect to monomer conversion (82–99%), product dispersity (<1.25), and molecular weight control (up to 100 000). For this purpose, different chlorine-based initiators in conjunction with the CuCl/CuCl2/PMDETA catalytic system were used. The utility of the optimized method in the biomedical field was demonstrated in the preparation of the poly(HPMA)-based copolymeric carrier having the anti-cancer drug doxorubicin conjugated through a pH-sensitive hydrazone linker.

Graphical abstract: Optimizing the Cu-RDRP of N-(2-hydroxypropyl) methacrylamide toward biomedical applications

Supplementary files

Article information

Article type
Communication
Submitted
05 Nov 2018
Accepted
06 Dec 2018
First published
07 Dec 2018

Polym. Chem., 2019,10, 564-568

Optimizing the Cu-RDRP of N-(2-hydroxypropyl) methacrylamide toward biomedical applications

V. Raus and L. Kostka, Polym. Chem., 2019, 10, 564 DOI: 10.1039/C8PY01569D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements